- You can view the full Edwards Life Sciences Ratings Report.
- Use our health services section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Concert must submit toxicology data to the FDA before proceeding with Phase 2 trials.
Canaccord is bullish on Edwards Lifescience stock.